GX Molecular Inc. — Form D
GX Molecular Inc. of CAMBRIDGE, X0, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-10. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-10
- Form: D
- Accession: 0001866545-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $2.2M
- Investors: 9
- Date of first sale: 2021-05-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-402424
Issuer
- Name: GX Molecular Inc.
- CIK: 0001866545
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: WEWORK 50-60 STATION ROAD, CAMBRIDGE, X0, CB1 2JH
- Phone: 44 0 784 588 9519
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| JEREMY DICKINSON PRESTON | Executive Officer | CAMBRIDGE, X0 |
| LUCAS EDELMAN | Director | CAMBRIDGE, X0 |
| LUCAS EDELMAN | Executive Officer | CAMBRIDGE, X0 |
Other filings by this issuer (1)
More